From Russia with review [RSABE / ABEL]

posted by mittyri – Russia, 2019-12-04 12:29 (1161 d 04:16 ago) – Posting: # 20917
Views: 5,638

Hi Helmut,

❝ Since three authors are members of the “Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation” (and the first one is the head of the department): Are the conclusions really a recommendation?


I would translate the sentence in the last paragraph before conclusion as:
Currently the discussions related to reference scaling modification are going on.
Conclusion says that it is just a review, not a recommendation.

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
18 visitors (0 registered, 18 guests [including 6 identified bots]).
Forum time: 16:46 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5